Growth Metrics

BeOne Medicines (ONC) Current Leases (2019 - 2025)

Historic Current Leases for BeOne Medicines (ONC) over the last 7 years, with Q3 2025 value amounting to $15.7 million.

  • BeOne Medicines' Current Leases fell 1115.38% to $15.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year decrease of 1115.38%. This contributed to the annual value of $17.6 million for FY2024, which is 1992.71% down from last year.
  • Per BeOne Medicines' latest filing, its Current Leases stood at $15.7 million for Q3 2025, which was down 1115.38% from $17.2 million recorded in Q2 2025.
  • BeOne Medicines' Current Leases' 5-year high stood at $24.8 million during Q2 2022, with a 5-year trough of $14.0 million in Q1 2021.
  • In the last 5 years, BeOne Medicines' Current Leases had a median value of $19.4 million in 2024 and averaged $20.2 million.
  • As far as peak fluctuations go, BeOne Medicines' Current Leases skyrocketed by 6361.04% in 2022, and later tumbled by 2488.51% in 2024.
  • Over the past 5 years, BeOne Medicines' Current Leases (Quarter) stood at $21.9 million in 2021, then rose by 9.65% to $24.0 million in 2022, then dropped by 8.7% to $22.0 million in 2023, then fell by 19.93% to $17.6 million in 2024, then fell by 10.49% to $15.7 million in 2025.
  • Its Current Leases stands at $15.7 million for Q3 2025, versus $17.2 million for Q2 2025 and $18.3 million for Q1 2025.